Literature DB >> 9502400

The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer.

M A Shibata1, C L Jorcyk, M L Liu, K Yoshidome, L G Gold, J E Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9502400     DOI： 10.1177/019262339802600121

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN： 0192-6233            Impact factor:   1.902


× No keyword cloud information.
  18 in total

Review 1.  Interrogating mouse mammary cancer models: insights from gene expression profiling.

Authors:  Antonio A Fargiano; Kartiki V Desai; Jeffrey E Green
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

2.  Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice.

Authors:  Amy Brock; Silva Krause; Hu Li; Marek Kowalski; Michael S Goldberg; James J Collins; Donald E Ingber
Journal:  Sci Transl Med       Date:  2014-01-01       Impact factor: 17.956

3.  Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.

Authors:  M J Hoenerhoff; M A Shibata; A Bode; J E Green
Journal:  Transgenic Res       Date:  2010-06-12       Impact factor: 2.788

4.  Benefits of exercise training on breast cancer progression and inflammation in C3(1)SV40Tag mice.

Authors:  E A Murphy; J M Davis; T L Barrilleaux; J L McClellan; J L Steiner; M D Carmichael; M M Pena; J R Hebert; J E Green
Journal:  Cytokine       Date:  2011-05-19       Impact factor: 3.861

5.  A kinase activity associated with simian virus 40 large T antigen phosphorylates upstream binding factor (UBF) and promotes formation of a stable initiation complex between UBF and SL1.

Authors:  W Zhai; L Comai
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

6.  Prostatic intraepithelial neoplasia in genetically engineered mice.

Authors:  Jae-Hak Park; Judy E Walls; Jose J Galvez; Minjung Kim; Cory Abate-Shen; Michael M Shen; Robert D Cardiff
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer.

Authors:  Jl Steiner; Jm Davis; Jl McClellan; Rt Enos; Ja Carson; R Fayad; M Nagarkatti; Ps Nagarkatti; D Altomare; Ke Creek; Ea Murphy
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

8.  Suppression of tumor formation by a cyclooxygenase-2 inhibitor and a peroxisome proliferator-activated receptor gamma agonist in an in vivo mouse model of spontaneous breast cancer.

Authors:  Aladdin Mustafa; Warren D Kruger
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

Review 9.  Genetically engineered mouse models of prostate cancer.

Authors:  Maxime Parisotto; Daniel Metzger
Journal:  Mol Oncol       Date:  2013-02-14       Impact factor: 6.603

10.  Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.

Authors:  J L Steiner; J M Davis; J L McClellan; A Guglielmotti; E A Murphy
Journal:  Cytokine       Date:  2014-01-20       Impact factor: 3.861
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.